Sarepta Therapeutics: Beaten Down, But Not Out
Sarepta Therapeutics(US:SRPT) Seeking Alphaยท2025-07-28 08:17Group 1 - Sarepta Therapeutics (SRPT) has experienced a significant decline in stock value, down more than 90% year-to-date [1] - The company has faced a series of negative events, including paused drug shipments and patient deaths [1]